Cmv Clinical Trials

• Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-Seronegative Healthy Male Adult Subjects
  ClinicalTrials.gov Identifier: NCT00435396 - Active, not recruiting
  Cytomegalovirus
  
• Adoptive Immunotherapy for CMV Disease
  ClinicalTrials.gov Identifier: NCT00159055 - Recruiting
  CMV Disease
  
• Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge
  ClinicalTrials.gov Identifier: NCT00373412 - Active, not recruiting
  Cytomegalovirus Infection
  
• Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
  ClinicalTrials.gov Identifier: NCT00547235 - Recruiting
  Infection; Precancerous/Nonmalignant Condition
  
• Recombinant CMV gB Vaccine in Postpartum Women
  ClinicalTrials.gov Identifier: NCT00125502 - Active, not recruiting
  Cytomegalovirus Infections
  
• CMV-Ig Replacement in Hypogammaglobulinemic Lung Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00137748 - Active, not recruiting
  Lung Transplantation; Hypogammaglobulinemia
  
• GB/MF59 Vaccine in Preventing CMV Infection in Healthy Adolescent Females
  ClinicalTrials.gov Identifier: NCT00133497 - Recruiting
  Cytomegalovirus Infections
  
• The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis
  ClinicalTrials.gov Identifier: NCT00341172 - Active, not recruiting
  CMV Disease
  
• A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)
  ClinicalTrials.gov Identifier: NCT00439803 - Active, not recruiting
  Cytomegalovirus Infections
  
• Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00436384 - Active, not recruiting
  Transplant
  
• Evaluation of Interferon-Gamma Responses to HCMV Infection in HIV Positive Individuals
  ClinicalTrials.gov Identifier: NCT00168259 - Active, not recruiting
  HIV Infections; CMV
  
• The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease
  ClinicalTrials.gov Identifier: NCT00214240 - Active, not recruiting
  Cytomegalovirus
  
• CMV Infection in Adolescent Males
  ClinicalTrials.gov Identifier: NCT00302029 - Recruiting
  Cytomegalovirus Infections
  
• CMV Glycoprotein B Vaccine in Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00299260 - Recruiting
  Cytomegalovirus Infections
  
• IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00294515 - Active, not recruiting
  Cytomegalovirus Infections
  
• Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
  ClinicalTrials.gov Identifier: NCT00225394 - Completed
  CMV Disease; Viral Resistance; Rejection; Death
  
• VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00431353 - Active, not recruiting
  Cytomegalovirus Infections
  
• A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00372229 - Recruiting
  Cytomegalovirus Infections
  
• Valganciclovir in Prevention of CMV Reactivation Following Allo-SCT
  ClinicalTrials.gov Identifier: NCT00330018 - Recruiting
  Bone Marrow Transplantation; Cytomegalovirus
  
• Follow-Up Assessment of Subjects Who Received Ganciclovir for CMV Infections
  ClinicalTrials.gov Identifier: NCT00031421 - Active, not recruiting
  Cytomegalovirus Infections
  
• The Study is Being Done to See If Taking the Drug Valganciclovir Can Prevent CMV Infection.
  ClinicalTrials.gov Identifier: NCT00275665 - Recruiting
  Bone Marrow Stem Cell Transplant
  
• Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00002673 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• CMV Disease and IRIS in HIV-1 Infected Persons
  ClinicalTrials.gov Identifier: NCT00456664 - Recruiting
  HIV Infections; Cytomegalovirus
  
• Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00227370 - Recruiting
  Cytomegalovirus Infections
  
• Assessment of valganciclovir in neonates with CMV
  ClinicalTrials.gov Identifier: NCT00031434 - Active, not recruiting
  Cytomegalovirus Infections
  
• A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Solid Organ Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00273156 - Recruiting
  Cytomegalovirus Infection
  
• Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00284687 - Recruiting
  Cytomegalovirus Infections
  
• Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00411645 - Recruiting
  Cytomegalovirus Infections
  
• Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00497796 - Recruiting
  Cytomegalovirus Infections
  
• A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00000698 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS Who Have Not Had Success with Ganciclovir
  ClinicalTrials.gov Identifier: NCT00002301 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Cytomegalovirus (CMV) Infection in Pregnancy
  ClinicalTrials.gov Identifier: NCT00194155 - Active, not recruiting
  Pregnancy Complications; Cytomegalovirus Infection
  
• Valganciclovir in Patients with CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
  ClinicalTrials.gov Identifier: NCT00017784 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002384 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection.
  ClinicalTrials.gov Identifier: NCT00400322 - Recruiting
  Glioblastoma Multiforme; Cytomegalovirus Infection
  
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients with HIV
  ClinicalTrials.gov Identifier: NCT00001034 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections; Gastrointestinal Diseases
  
• Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
  ClinicalTrials.gov Identifier: NCT00000143 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Influence of Persistent CMV-Infection on Immune Senescence
  ClinicalTrials.gov Identifier: NCT00461695 - Recruiting
  Immune Senescence
  
• MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
  ClinicalTrials.gov Identifier: NCT00237653 - Recruiting
  Cytomegalovirus Infections; Inflammatory Bowel Diseases
  
• Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
  ClinicalTrials.gov Identifier: NCT00285259 - Recruiting
  Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Acute Myelogenous Leukemia; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Myelodysplastic Syndrome
  
• Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns with Symptomatic Congenital CMV Infection without Central Nervous System Disease
  ClinicalTrials.gov Identifier: NCT00004642 - Completed
  Cytomegalovirus Infections
  
• Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
  ClinicalTrials.gov Identifier: NCT00466817 - Not yet recruiting
  Cytomegalovirus Infections
  
• Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00078533 - Recruiting
  Stem Cell Transplantation; Cytomegalovirus Infections
  
• Virus-Specific Cytotoxic T-Lymphocytes (CTLs) for Adenovirus Infection Post Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00111033 - Recruiting
  Adenovirus Infection
  
• CMV Infection in Amniotic Fluid
  ClinicalTrials.gov Identifier: NCT00194142 - Not yet recruiting
  Pregnancy; Cytomegalovirus
  
• Maribavir for Prevention of CMV After Stem Cell Transplants
  ClinicalTrials.gov Identifier: NCT00223925 - Completed
  Cytomegalovirus Infection
  
• The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial
  ClinicalTrials.gov Identifier: NCT00566072 - Completed
  Cytomegalovirus Infections
  
• Response of Older Adults to Influenza Vaccination With Regard to CMV Status
  ClinicalTrials.gov Identifier: NCT00442975 - Completed
  Influenza
  
• A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00273143 - Completed
  Cytomegalovirus Infection
  
• Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
  ClinicalTrials.gov Identifier: NCT00370006 - Completed
  Cytomegalovirus Infection
  
• Evaluation of the Immunogenicity and Efficacy of the Towne Strain of CMV in Seronegative Women
  ClinicalTrials.gov Identifier: NCT00201448 - Suspended
  Cytomegalovirus Infections
  
• The Safety and Effectiveness of ISIS 2922 in Patients with AIDS Who Have Cytomegalovirus (CMV) of the Eyes
  ClinicalTrials.gov Identifier: NCT00002356 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Comparison of ISIS 2922 Used Immediately or Later in Patients with Cytomegalovirus (CMV) of the Eyes
  ClinicalTrials.gov Identifier: NCT00002355 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00000981 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• CMV Retinitis Retreatment Trial
  ClinicalTrials.gov Identifier: NCT00000766 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
  ClinicalTrials.gov Identifier: NCT00002095 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002373 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
  ClinicalTrials.gov Identifier: NCT00000142 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
  ClinicalTrials.gov Identifier: NCT00000135 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
  ClinicalTrials.gov Identifier: NCT00002135 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of Ganciclovir Used Alone or in Combination with Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00000989 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002437 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00000726 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)
  ClinicalTrials.gov Identifier: NCT00000836 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00002039 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
  ClinicalTrials.gov Identifier: NCT00001100 - Completed
  Cytomegalovirus Infections
  
• A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
  ClinicalTrials.gov Identifier: NCT00002268 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002432 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002330 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00002016 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)
  ClinicalTrials.gov Identifier: NCT00002125 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
  ClinicalTrials.gov Identifier: NCT00000136 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
  ClinicalTrials.gov Identifier: NCT00000799 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of AZT Plus Ganciclovir in Patients with AIDS and Cytomegalovirus (CMV) Infection
  ClinicalTrials.gov Identifier: NCT00000995 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients with AIDS Who Have CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00000894 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
  ClinicalTrials.gov Identifier: NCT00000665 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Efficacy of Elevated CD4 Counts on CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00091884 - Completed
  Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis
  
• A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00000673 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
  ClinicalTrials.gov Identifier: NCT00000691 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis after Effective Anti-HIV Therapy
  ClinicalTrials.gov Identifier: NCT00000905 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Preventing Cytomegalovirus (CMV) Organ Damage with Valganciclovir in People with HIV
  ClinicalTrials.gov Identifier: NCT00006145 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
  ClinicalTrials.gov Identifier: NCT00002377 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002299 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00001999 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase I Study of the Safety of Proleukin (aldesleukin) in Combination with Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
  ClinicalTrials.gov Identifier: NCT00002321 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002222 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease
  ClinicalTrials.gov Identifier: NCT00002145 - Completed
  HIV Infections; Gastrointestinal Diseases
  
• Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00002070 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
  ClinicalTrials.gov Identifier: NCT00001531 - Completed
  Arterial Occlusive Diseases; Atherosclerosis; Coronary Disease; Cytomegalovirus Infections
  
• A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001089 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
  ClinicalTrials.gov Identifier: NCT00057915 - Completed
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00027534 - Completed
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
  
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS Who Cannot Use Ganciclovir
  ClinicalTrials.gov Identifier: NCT00000697 - Terminated
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
  ClinicalTrials.gov Identifier: NCT00000856 - Terminated
  Encephalopathy; HIV Infections; Radiculitis
  
• A Study of Cidofovir in HIV-Infected Children with Cytomegalovirus (CMV) Disease
  ClinicalTrials.gov Identifier: NCT00000881 - Terminated
  Cytomegalovirus Infections; Cytomegalovirus Retinitis; HIV Infections